Benzinga | Nov 11, 2020 04:11PM EST

TELA Bio Q3 EPS $(0.53) Misses $(0.49) Estimate, Sales $5.30M Beat $4.58M Estimate

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.49) by 8.16 percent. This is a 97.65 percent increase over losses of $(22.58) per share from the same period last year. The company reported quarterly sales of $5.30 million which beat the analyst consensus estimate of $4.58 million by 15.72 percent. This is a 33.40 percent increase over sales of $3.97 million the same period last year.